Janney Capital Management LLC lifted its holdings in Masimo Co. (NASDAQ:MASI) by 45.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,911 shares of the medical equipment provider’s stock after acquiring an additional 1,529 shares during the period. Janney Capital Management LLC’s holdings in Masimo were worth $425,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also bought and sold shares of the company. Fortaleza Asset Management Inc. bought a new position in shares of Masimo in the 2nd quarter worth about $106,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Masimo by 13.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock worth $184,000 after acquiring an additional 236 shares in the last quarter. DekaBank Deutsche Girozentrale raised its position in shares of Masimo by 78.3% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock worth $182,000 after acquiring an additional 925 shares in the last quarter. Advisor Group Inc. grew its stake in shares of Masimo by 38.4% in the 2nd quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock valued at $216,000 after buying an additional 655 shares during the period. Finally, Daiwa Securities Group Inc. acquired a new stake in shares of Masimo in the 2nd quarter valued at about $219,000. 83.74% of the stock is owned by hedge funds and other institutional investors.
Several analysts have recently commented on the company. BidaskClub downgraded Masimo from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. BTIG Research upgraded Masimo from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Monday, August 14th. Zacks Investment Research downgraded Masimo from a “buy” rating to a “hold” rating in a research note on Tuesday, October 3rd. Finally, Stifel Nicolaus restated a “buy” rating and issued a $108.00 target price on shares of Masimo in a research note on Friday, November 3rd. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $97.17.
Masimo Co. (MASI) opened at $85.50 on Tuesday. The stock has a market capitalization of $4,420.00, a PE ratio of 32.95, a price-to-earnings-growth ratio of 2.90 and a beta of 0.72. Masimo Co. has a 12 month low of $64.12 and a 12 month high of $104.71.
Masimo (NASDAQ:MASI) last released its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.53 by $0.17. The business had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. Masimo had a return on equity of 22.17% and a net margin of 45.83%. The company’s quarterly revenue was up 15.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.52 EPS. equities research analysts expect that Masimo Co. will post 2.95 earnings per share for the current year.
In other Masimo news, EVP Yongsam Lee sold 18,198 shares of Masimo stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $88.85, for a total transaction of $1,616,892.30. Following the completion of the transaction, the executive vice president now owns 70,800 shares in the company, valued at approximately $6,290,580. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven Barker sold 10,000 shares of Masimo stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total value of $900,000.00. Following the transaction, the director now owns 73,249 shares of the company’s stock, valued at approximately $6,592,410. The disclosure for this sale can be found here. Insiders have sold a total of 53,074 shares of company stock valued at $4,737,245 in the last quarter. Company insiders own 13.10% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Masimo Co. (MASI) Shares Bought by Janney Capital Management LLC” was published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.thelincolnianonline.com/2017/12/12/masimo-co-masi-shares-bought-by-janney-capital-management-llc.html.
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Co. and related companies with MarketBeat.com's FREE daily email newsletter.